

Researchers have finally cracked the code on how Epstein-Barr virus leads to multiple sclerosis, opening the door to better treatments for the 2.

9 million people living with the disease worldwide.

The breakthrough also reveals why existing immunotherapy drugs work so well at slowing the condition.

Want to know more?